Effect of Calcium Glycerophosphate (CaGP) - Fluoride Dentifrice on Dental Biofilm pH
NCT ID: NCT00875212
Last Updated: 2009-10-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
12 participants
INTERVENTIONAL
2006-01-31
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Chewing a Calcium Supplement Before Fluoride Rinse on Salivary Fluoride
NCT04620252
Evaluation of the Anti-cavity Efficacy of Three Dentifrices Using an Intra-oral Enamel Demineralization - Remineralization In-Situ Model
NCT06732518
Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice
NCT01657877
Caries-preventive Effect of a Dentifrice Containing 5,000 Ppm Fluoride in Orthodontic Patients
NCT01768390
Dentifrice With Innovative Remineralizing Technology
NCT04730908
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dentifrice intervention
4 types of dentifrices were used in 4 different periods in a crossover study design.
calcium glycerophosphate
use of a dentifrice containing CaGP (0.13%) and no fluoride
no active ingredient
dentifrice without calcium glycerophosphate and no fluoride
fluoride
use of a dentifrice containing fluoride (1500ppm) only
CAGP + fluoride
calcium glycerophosphate and fluoride dentifrice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
calcium glycerophosphate
use of a dentifrice containing CaGP (0.13%) and no fluoride
no active ingredient
dentifrice without calcium glycerophosphate and no fluoride
fluoride
use of a dentifrice containing fluoride (1500ppm) only
CAGP + fluoride
calcium glycerophosphate and fluoride dentifrice
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* to have at least 20 natural teeth
* signed a consent form agreeing to carefully follow the research instructions
Exclusion Criteria
* periodontal disease
* use of antibiotics/medication.
19 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Conselho Nacional de Desenvolvimento Científico e Tecnológico
OTHER_GOV
Coordination for the Improvement of Higher Education Personnel
OTHER
Federal University of Paraíba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Coordination for the Improvement of Higher Education Personnel
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabio C Sampaio, PhD
Role: PRINCIPAL_INVESTIGATOR
Federal University of Paraiba
Thiago S Carvalho, Master
Role: STUDY_CHAIR
Federal University of Paraiba
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Science Centre at the Federal University of Paraiba
João Pessoa, Paraíba, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CNPq?PIBIC?UFPB_2005
Identifier Type: -
Identifier Source: secondary_id
UFPB-CAPES_2005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.